WO2005035559A1 - Isoliertes photoprotein mtclytin, sowie dessen verwendung - Google Patents
Isoliertes photoprotein mtclytin, sowie dessen verwendung Download PDFInfo
- Publication number
- WO2005035559A1 WO2005035559A1 PCT/EP2004/009843 EP2004009843W WO2005035559A1 WO 2005035559 A1 WO2005035559 A1 WO 2005035559A1 EP 2004009843 W EP2004009843 W EP 2004009843W WO 2005035559 A1 WO2005035559 A1 WO 2005035559A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- seq
- photoprotein
- sequence
- acid molecules
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Definitions
- the invention relates to the photoprotein mtClytin, its nucleotide and amino acid sequence, and the activity and use of the photoprotein mtClytin.
- Bioluminescence is the phenomenon of light generation by living things. It is the result of biochemical reactions in cells in which the chemical energy is released in the form of light quanta (so-called cold emission through chemiluminescence). Light generated in this way is monochromatic, because it is emitted with a discrete electron transition, but can be shifted into longer-wave spectral ranges by secondary fluorescent dyes (e.g. fluorescent proteins in the case of light jellyfish of the genus Aequora).
- secondary fluorescent dyes e.g. fluorescent proteins in the case of light jellyfish of the genus Aequora
- the biological function is diverse: around 90% of all living things shine in the sea depth between 200 and 1000 m (mesopelagial).
- the light signals are used here for partner advertising, deception and as bait. Fireflies and fireflies also use the light signals to find partners.
- a large number of coelenterates are bioluminescent (Morin et al., 1974). These organisms emit blue or green light.
- the aequorin from Aequoria victoria identified as the first light producing protein in 1962 (Shimomura et al., 1969) emitted a blue light and not green light as phenotypically observed in Aequoria victoria as the isolated protein.
- GFP green fluorescent protein
- Table 2 Overview of some photoproteins. The organism from which the protein has been isolated, the name of the photoprotein and a selection are given. Patents or registrations.
- Bioluminescence is widely used in technology today, e.g. in the form of bio-indicators for environmental pollution or in biochemistry angry sensitive detection of proteins, for the quantification of certain compounds or as a so-called "reporter” in the study of cellular gene regulation.
- the photoproteins differ not only because of their nucleotide and amino acid sequence, but also because of their biochemical and physical properties. It could be shown that changing the amino acid sequence of photoproteins can change the physical and biochemical properties. Examples of mutagenized photoproteins are described in the literature (US 6,495,355; US 5,541,309; US 5,093,240; Shimomura et al., 1986).
- Reporter or indicator genes are generally referred to as genes whose gene products can be easily detected using simple biochemical or histochemical methods. A distinction is made between at least 2 types of reporter genes.
- Resistance genes are genes whose expression gives a cell resistance to antibiotics or other substances, the presence of which in the growth medium leads to cell death if the resistance gene is missing.
- Reporter genes are used in genetic engineering as merged or unfused indicators. The most common reporter genes include beta-galactosidase (Alam et al., 1990), alkaline phospatase (Yang et al., 1997; Cullen et al., 1992), luciferases and other photoproteins (Shinomura, 1985; Phillips GN, 1997; Snowdowne et al., 1984).
- Luminescence is the radiation of photons in the visible spectral range, this being done by excited emitter molecules. In contrast to fluorescence, the energy is not supplied from outside in the form of radiation of shorter wavelength.
- Chemiluminescence is a chemical reaction that leads to an excited molecule that glows when the excited electrons return to the ground state. If this reaction is catalyzed by an enzyme, one speaks of bioluminescence.
- the enzymes involved in the reaction are generally referred to as luciferases.
- the species Clytia grenaria belongs to the Cnidaria, especially to the Medusas.
- the bioluminescent or fiuorescent phenotype was already described in 1998 (Ward et al., 1998). Isolation of the cDNA
- reaction products were incubated for 30 minutes at 37 ° C. with proteinase K and the cDNA was precipitated with ethanol.
- the expression cDNA bank was carried out using the “SMART cDNA Library Construction Kit” from Clontech (USA) according to the manufacturer's instructions.
- the cloning was carried out into the expression vector pTriplEx2 (Clontech; USA).
- the expression vectors were electroplated into bacteria of strain E. coli XLl-Blue transformed.
- the bacteria were plated on LB culture media and incubated for 24 hours at 37 ° C. Replica plating was then carried out by transferring the bacteria to a further culture medium plate using a nitrocellulose filter. The replica plate was again incubated for 24 hours at 37 ° C. and the grown bacterial colonies were transferred to LB liquid medium. After the addition of IPTG (final concentration 0.1 mM), the bacteria were incubated for 4 hours at 37 ° C. on a shaker. The bacteria were harvested by centrifugation and the bacterial mass was resuspended in 0.5 ml digestion buffer (5 mM EDTA, 20 mM Tris-HCL pH 9.0) at 0 ° C. The bacteria were then broken down ⁇ by ultrasound.
- IPTG final concentration 0.1 mM
- the lysates. were incubated at 4 ° C for 3 hours after the addition of coelenterazines (final concentration 10E-07 M). The bioluminescence was then measured after the addition of calcium chloride (final concentration 20 mM) in the luminometer.
- a photoprotein was identified.
- the photoprotein was named mtClytin.
- the mtClytin photoprotein is shown in detail below.
- the photoprotein mtClytin shows the highest homology at the amino acid level to clytine from Clytia gregaria with an identity of 87% and to obelin from Obelia geniculata an identity of 77% (shown in Example 8; FIG. 8).
- the homology of 87% - in relation to clytin - results at the C-terminal end of the protein, whereby multiple amino acid exchanges can be identified distributed over the entire protein.
- the identity is below 30% (shown in Example 7; FIG. 7).
- the BLAST method was used for sequence comparison (Altschul et al., 1997).
- the photoprotein clytin-2 shows the highest homology at the amino acid level to clytin from Cyltia gregaria. However, the sequence has a number of deviations in the amino acid sequence, which are shown in Example 11 (FIG. 9). These deviations can lead to changed physicochemical, biochemical and bioluminescent properties.
- the photoprotein clytin-2 has no signal peptide (as shown in Example 10).
- the photoprotein mtClytin has a signal peptide that can lead to translocation of the photoprotein in mitochondria.
- the signal peptide was identified by the computer program MITOPROT (Claros et al., 1996) (shown in Example 10).
- the signal peptide determined by MITOPROT is given in SEQ _D NO: 3.
- the mtClytin photoprotein is the first photoprotein to identify a natural signal peptide for translocation in mitochondria.
- the invention also relates to functional equivalents of mtClytin.
- Functional equivalents are those proteins which have comparable physicochemical properties and are at least 70% homologous to SEQ ID NO: 2. A homology of at least 80% or 90% is preferred. A homology of at least 95% is particularly preferred.
- the invention also relates to the functional equivalents of the mtClytin signal peptide.
- Functional equivalents are those proteins or peptides that have comparable physicochemical properties and are at least 70% homologous to SEQ ID NO: 3. A homology of at least 80% or 90% is preferred. A homology of at least 95% is particularly preferred.
- the photoprotein mtClytin is suitable as a reporter gene for cellular systems especially for receptors, for ion channels, for transporters, for transcription factors or for inducible systems.
- the signal peptide from mtClytin is also suitable as a fusion with reporter genes as a fused reporter gene for cellular systems, especially for repores, for ion channels, for transporters, for transcription factors or for inducible systems.
- the photoprotein mtClytin is also suitable as a reporter gene through labeling, identification and characterization of cell organelles especially for mitochondria.
- the signal peptide from mtClytin is also suitable for fusion with peptides or proteins for translocation in cell organelles, especially mitochondria.
- MtClytin's photoprotein is also suitable as a reporter gene for determining parameters inside and outside cell organelles, especially mitochondria, especially calcium concentrations.
- the signal peptide from mtClytin is also suitable as a fusion peptide as a reporter gene for determining • parameters inside and outside of cell organelles, especially mitochondria, especially calcium concentrations.
- the photoprotein mtClytm is suitable as a reporter gene in bacterial and eukaryotic systems, especially in mammalian cells, in bacteria, in yeast, in Bakulo, in plants.
- the photoprotein mtClytm is suitable as a reporter gene for cellular systems in combination with bioluminescent or chemiluminescent systems, especially systems with luciferases, with oxygenases, with phosphatases.
- the signal peptide from mtClytin is also suitable as a fusion peptide as a reporter gene for cellular systems n ' combination with bioluminescent or chemiluminescent systems, especially systems with luciferases, with oxygenases, with phosphatases.
- the photoprotein mtClytin is suitable as a fusion protein especially for receptors, for ion channels, for transporters, for transcription factors, for proteinases, for kinases, for phosphodiesterases, for hydrolases, for peptidases, for transferases, for membrane proteins and for glycoproteins.
- the signal peptide from mtClytin is suitable as a fusion peptide as a fusion protein especially for receptors, for ion channels, for transporters, for transcription factors, for proteinases, for kinases, for phosphodiesterases, for hydrolases, for peptidases, for transferases, for membrane proteins and for glycoproteins.
- the photoprotein mtClytin is particularly suitable for immobilization by antibodies, by biotin, by magnetic or magnetizable carriers.
- the mtClytm photoprotein is suitable as a protein for energy transfer systems, especially FRET (Fluorescence Resonance Energy Transfer), BRET (Bioluminescence Resonance Energy Transfer), FET (field effect transistors), FP (fluorescence polarization), HTRF (Homogeneous time-resolved fluorescence) systems.
- the photoprotein mtClytm is suitable as a label for substrates or ligands especially for proteases, for kinases, for transferases.
- the photoprotein mtClytin is suitable for expression in bacterial systems especially for titer determination, as a substrate for biochemical systems especially for proteinases and kinases.
- the photoprotein mtClytin is suitable as a marker specially linked to antibodies, linked to enzymes, linked to receptors, linked to ion channels and other proteins.
- the signal peptide from mtClytm is also suitable as a fusion peptide as a marker specially linked to antibodies, linked to enzymes, linked to receptors, linked to ion channels and other proteins.
- the photoprotein mtClytm is suitable as a reporter gene for pharmacological drug searches, especially in HTS (High Throughput Screening).
- the signal peptide from mtClytin is also suitable as a reporter gene for pharmacological drug searches, especially in HTS (High Throughput Screening).
- the mtClytm photoprotein is suitable as a component of detection systems especially for ELISA (enzyme-linked immunosorbent assay), for immunohistochemistry, for Western blot, for confocal microscopy.
- ELISA enzyme-linked immunosorbent assay
- the photo mtClytin is suitable as a marker for the analysis of interactions, especially for protein-protein interactions, for DNA-protein interactions, for DNA-RNA interactions, RNA-RNA Wech 'sel füren, for RNA-protein interactions ( DNA: deoxyribonucleic acid; RNA: ribonucleic acid;).
- the photoprotein mtClytin is suitable as a marker or fusion protein for expression in transgenic organisms, especially in mice, in rats, in hamsters and other mammals, in primates, in fish, in worms, in plants.
- the signal peptide from mtClytm is also suitable as a fusion peptide as a marker or fusion protein • for expression in transgenic organisms, especially in mice, in rats, in hamsters and other mammals, in primates, in fish, in worms, in plants.
- the photoprotein mtClytin is suitable as a marker or fusion protein for analyzing embryonic development.
- the photoprotein mtClytin is suitable as a marker via a coupling agent, especially via biotin, via NHS (N-hydroxysulfosuccimide), via CN-Br.
- the photoprotein mtClytin is suitable as a reporter coupled to nucleic acids, especially to DNA, to RNA.
- the mtClytm photoprotein is suitable as a reporter coupled to proteins or peptides.
- the mtClytin signal peptide is also suitable as a fusion peptide as a reporter coupled to proteins or peptides.
- the photoprotein mtClytin is suitable as a reporter for measuring intra- or extracellular calcium concentrations.
- the mtClytin photoprotein is suitable for characterizing signal cascades in cellular systems.
- the mtClytm photoprotein coupled to nucleic acids or peptides is particularly suitable as a probe for Northern blots, for Southern blots, for Western blots, for ELISA, for nucleic acid sequencing, for protein analysis, chip analysis.
- the photoprotein mtClytm is suitable for labeling pharmacological formulations, especially of infectious agents, of antibodies, of "small molecules".
- the photoprotein mtClytin is suitable for geological investigations especially for ocean, groundwater and river currents.
- the photoprotein mtClytm is suitable for expression in expression systems, especially in in vitro translation systems, in bacterial systems, in yeast systems, in Bakulo systems, in viral systems, in eukaryotic systems. •
- the mtClytin signal peptide is also suitable as a fusion peptide for expression in expression systems, especially in in-vitro translation systems, in bacterial systems, in yeast systems, in Bakulo systems, in viral systems, in eukaryotic systems.
- the photoprotein mtClytin is suitable for the visualization of tissues or cells during surgery, especially for invasive, non-invasive, and minimally invasive.
- the photoprotein mtClytm is also suitable for marking tumor tissues and other phenotypically modified tissues, especially for histological examinations and surgical interventions.
- the invention also relates to the purification of the photoprotein mtClytm, especially as a wild-type protein, as a fusion protein, as a mutagenized protein.
- the invention also relates to the purification of the signal peptide from mtClytin, especially as a wild-type protein, as a fusion protein, as a mutagenized protein.
- the invention also relates to the use of the photoprotein mtClytin in the field of cosmetics, especially bath additives, lotions, soaps, body colors, toothpaste, body powders.
- the invention also relates to the use of the photoprotein mtClytin for coloring food, bath additives, ink, textiles and plastics.
- the invention also relates to the use of the photoprotein mtClytin for coloring paper, especially greeting cards, paper products, wallpapers, handicrafts.
- the invention also relates to the use of the photoprotein mtClytin for coloring liquids, especially for water pistols, for fountains, for drinks, for ice.
- the invention also relates to the use of the photoprotein mtClytin for the production of toys, especially of finger paint, of make-up.
- the invention relates to nucleic acid molecules that encode the polypeptide disclosed by SEQ ID NO: 2.
- the invention relates to nucleic acid molecules that encode the polypeptide disclosed by SEQ ID NO: 3.
- the invention relates to nucleic acid molecules which encode the polypeptide disclosed by SEQ ID NO: 6.
- the invention relates to the polypeptide with the amino acid sequence disclosed in SEQ ID NO: 2.
- the invention relates to the polypeptide with the amino acid sequence disclosed in SEQ ID NO: 3.
- the invention relates to the polypeptide with the amino acid sequence disclosed in SEQ ID NO: 6.
- the invention further relates to nucleic acid molecules selected from the group consisting of
- nucleic acid molecules encoding a polypeptide which contains the amino acid sequence disclosed by SEQ ID NO: 2;
- nucleic acid molecules whose complementary strand hybridizes with a nucleic acid molecule from a) or b) under stringent conditions and which encode a polypeptide which has the biological function of a photoprotein;
- nucleic acid molecules which differ from those mentioned under c) due to the degeneracy of the genetic code
- nucleic acid molecules which have a sequence homology of at least 95% to SEQ ID NO: 1 and whose protein product has the biological function of a • photoprotein;
- nucleic acid molecules which have a sequence homology of at least 65% to SEQ ID NO: 1 and whose protein product has the biological function of a photoprotein.
- the invention also relates to nucleic acid molecules which have a sequence homology of at least 95%, 90%, 85%, 80%, 75%, 70%, 65% or 60% to SEQ ID NO: 1 or SEQ ID NO: 5 and for one Encode a polypeptide that has the properties of a photoprotein.
- the invention also relates to nucleic acid molecules which have a sequence homology of at least 95%, 90%, 85%, 80%, 75%, 70%, 65% or 60% to SEQ ID NO: 4 and code for a polypeptide which has the properties has a signal or leader peptide.
- the invention relates to the above-mentioned nucleic acid molecules, in which the sequence contains a functional promoter 5 "to the sequence coding for the photoprotein or the sequence coding for the leader or signal sequence.
- the invention also relates to nucleic acid molecules as described above, which are part of recombinant DNA or RNA vectors.
- the invention relates to organisms which contain such a vector.
- the invention relates to oligonucleotides with more than 10 consecutive nucleotides which are identical or complementary to the DNA or RNA sequence of the mtClytin molecules or the further molecules according to the invention.
- the invention relates to photoproteins which are encoded by the nucleotide sequences described above.
- the invention relates to methods for expressing the photoprotein polypeptides according to the invention in bacteria, eukaryotic cells or in in vitro expression systems.
- the invention also relates to methods for purifying / isolating a photoprotein polypeptide according to the invention.
- the invention relates to peptides with more than 5 consecutive amino acids which are recognized immunologically by antibodies against the photoproteins according to the invention.
- the invention relates to the use of the invention, photoprotein-encoding nucleic acids as marker or reporter genes, in particular for the pharmacological active ingredient 'search and diagnostics.
- the invention relates to the use of the photoproteins according to the invention or a nucleic acid according to the invention coding for a photoprotein as a marker or reporter or as a marker or reporter gene.
- the invention relates to the use of the mtClytm photoprotein (SEQ ID NO: 2) and the use of a nucleic acid coding for the mtClytin photoprotein as a marker or reporter or as a marker or reporter gene, in particular for pharmacological active ingredient search and diagnosis.
- the invention relates to the use of the nucleic acid shown in SEQ ID NO: 1 as a marker or reporter gene, in particular for pharmacological search for active substances and diagnostics.
- the invention relates to the use of the peptide shown in SEQ ID NO: 6 and the nucleic acid sequence SEQ ID NO: 5 on which this is based as a marker or reporter gene, in particular for pharmacological active ingredient search and diagnostics.
- the invention also relates to polyclonal or monocional antibodies which recognize a polypeptide according to the invention.
- the invention also relates to monocional or polyclonal antibodies which recognize the photoprotein mtClytin (SEQ ID NO: 2) or the photoprotein Clytin-2 (SEQ ID NO: 6).
- the invention also relates to monocional or polyclonal antibodies which recognize the signal peptide of the photoprotein mtClytm (SEQ ID NO: 3).
- the invention further relates to a nucleic acid molecule selected from the group consisting of
- nucleic acid molecules encoding a polypeptide which contains the amino acid sequence disclosed by SEQ ID NO: 3;
- nucleic acid molecules which contain the sequence shown in SEQ ID NO: 4;
- nucleic acid molecules whose complementary strand hybridizes with a nucleic acid molecule from a) or b) under stringent conditions and which encode a peptide which has the biological function of a signal or leader peptide;
- nucleic acid molecules which differ from those mentioned under c) due to the degeneracy of the genetic code
- nucleic acid molecules which show a sequence homology of at least 95% to SEQ ID NO: 4 and which encode a peptide which has the biological function of a signal or leader peptide;
- Nucleic acid molecules which show a sequence homology of at least 65% to SEQ ID NO: 4 and which encode a peptide which has the biological function of a signal or leader peptide.
- nucleic acid molecule selected from the group consisting of
- nucleic acid molecules encoding a polypeptide which contains the amino acid sequence disclosed by SEQ ID NO: 6; b) nucleic acid molecules which contain the sequence shown in SEQ ID NO: 5;
- Nuclear acid molecules the complementary strand of which hybridizes with a nucleic acid molecule from a) or b) under stringent conditions and which encode a polypeptide which has the biological function of a photoprotein;
- nucleic acid molecules which differ from those mentioned under c) due to the degeneracy of the genetic code
- nucleic acid molecules which show a sequence homology of at least 95% to SEQ ID NO: 5 and which encode a polypeptide which has the biological function of a photoprotein;
- Nuclear acid molecules which show at least 80% sequence homology to SEQ ID NO: 5 and which encode a polypeptide which has the biological function of a photoprotein.
- the invention also relates to a nucleic acid as described in the preceding paragraphs, which contains a functional promoter 5 'for the coding sequence.
- the invention includes recombinant DNA or RNA vectors which contain the nucleic acids described above.
- Organisms containing a vector as described above are also in accordance with the invention.
- the invention also relates to oligonucleotides with more than 10 consecutive nucleotides which are identical or complementary to a partial sequence of a nucleic acid molecule as described above.
- a polypeptide encoded by a nucleic acid sequence as described above is also part of the invention.
- According to the invention is also a method for the expression of the aforementioned polypeptides in bacteria, viral cells, yeast or eukaryotic cells or in in vitro expression systems.
- a method for the purification / isolation of a polypeptide according to the invention is also part of the invention.
- the invention are also peptides with more than 5 consecutive amino acids that are recognized immunologically by antibodies against the photoprotein mtClytin:
- the invention also includes peptides with more than 5 consecutive amino acids which are recognized immunologically by antibodies against the photoprotein clytin-2.
- Peptides with more than 5 consecutive are also part of the invention .
- Amino acids immunologically by antibodies against the signal or SEQ DD NO: 3.
- Leader peptide can be recognized.
- peptides with more than 5 consecutive amino acids that are recognized immunologically by antibodies against the photoprotein by SEQ ID NO: 6 (clytin-2).
- the invention relates to the use of a nucleic acid according to the invention as a marker or reporter gene.
- the invention also relates to the use of a photoprotein according to the invention as a marker or reporter.
- the invention relates to the use of a nucleic acid which has the sequence shown as SEQ ID NO: 4, or a sequence with 60%, 65%, 70%, 75%, 80%, 85% or 90%, preferably with 95% sequence identity to SEQ ID NO: 4, is included as a signal or leader sequence.
- a peptide which is the sequence shown as SEQ ID NO: 3, or a sequence with 60%, 65%, 70%, 75%, 80%, 85% or 90% , preferably with 95% sequence identity to SEQ ID NO: 3, is part of the invention as a signal or leader peptide.
- the cell organelles being mitochondria.
- the cell organelles being the endoplasmic reticulum (ER).
- the invention relates to the use of the nucleic acid sequence shown as SEQ ID NO: 4 as a signal or leader sequence.
- SEQ ID NO: 3 which contains the sequence shown, as a signal or leader peptide is also part of the invention.
- Also according to the invention is the use described in the two preceding paragraphs to transport a protein fused to the signal or leader peptide in cell organelles.
- the cell organelles being mitochondria.
- the cell organelles being the endoplasmic reticulum (ER).
- polypeptides according to the invention as reporter proteins in the pharmacological search for active substances is also part of the invention.
- the invention also relates to the use of the nucleic acids according to the invention as reporter genes in the pharmacological search for active substances.
- Expression refers to the production of a molecule which, after the gene has been introduced into a suitable host cell, allows the transcription and translation of the foreign gene cloned into an expression vector.
- Expression vectors contain the control signals required for the expression of genes in cells of prokaryotes or eukaryotes. ⁇
- expression vectors can be constructed in two different ways.
- transcription fusions the protein encoded by the cloned-in foreign gene is synthesized as an authentic, biologically active protein.
- the expression vector carries all 5 ⁇ and 3 'control signals required for expression.
- the protein encoded by the cloned-in foreign gene is expressed as a hybrid protein together with another protein that can be easily detected.
- the 5 'and 3 ⁇ control signals required for expression including the start codon and possibly some of the sequences coding for the N-terminal regions of the hybrid protein to be formed, come from the vector.
- the additional protein portion introduced not only stabilizes the protein encoded by the cloned foreign gene in many cases before it is broken down by cellular ones Proteases, but can also be used for the detection and isolation of the 'hybrid protein formed. Expression can be both transient and stable. Both bacteria, yeasts, viruses and eukaryotic systems are suitable as host organisms.
- protein purification The isolation of proteins (even after overexpression) is often referred to as protein purification.
- a variety of established methods and processes are available for protein purification.
- Solid-liquid separation is a basic operation in protein isolation.
- the process step is required both in the separation of the cells from the culture medium and in the clarification of the crude extract after cell disruption and removal of the cell debris, in the separation of precipitates after precipitation, etc. It is done by centrifugation and filtration.
- the cell wall must be destroyed or made permeable by obtaining intracellular proteins.
- high-pressure homogenizers or agitator ball or glass bead mills are used.
- mechanical cell integrations and ultrasound treatment are used.
- Extracellular proteins are obtained in relatively dilute solutions. Like extra-cellular proteins, they have to be concentrated before further use. In addition to the processes already mentioned, ultrafiltration has also proven itself - also on an industrial scale. Inorganic salts as accompanying substances in proteins are often undesirable for specific applications. They can be removed by gel filtration, dialysis and diafiltration, among others. ,
- Numerous proteins are used as dry preparations. Vacuum, freeze and spray drying are important drying methods.
- the mtClytm photoprotein is encoded by the following nucleotide sequence (SEQ ID NO: 1):
- the putative signal peptide of the photoprotein mtClytin has the following sequence (SEQ ID NO: 3):
- the photoprotein clytin-2 is encoded by the following nucleotide sequence (SEQ ID NO: 5): 5 - -
- Figure 1 shows the plasmid map of the vector pTriplEX2-mtClytin.
- Figure 2 shows the plasmid map of the vector pcDNA3 -mtClytin.
- Figure 3 shows the result of bacterial expression of mtClytin, and the bioluminescence activity of mtClytin after bacterial expression.
- Y RLU: relative light units
- X dilution
- black bars mtClytin
- gray bars control lysate
- Figure 4 shows the result of the eukaryotic expression of mtClytin, and the bioluminescence activity of mtClytin after expression in CHO Cells.
- Y RLU: relative light units
- X ATP (logarithmic representation in mol / 1)).
- Figure 7 shows the alignment of clytin and mtCyltin at the amino acid level.
- Figure 8 shows the alignment of clytin and mtCyltin at the nucleic acid level.
- Figure 9 shows the alignment of clytin, mtCyltin and Clytin-2 at the amino acid level.
- the plasmid pTriplEx2 from Clontech was used as the vector for producing the construct shown below.
- the derivative of the vector was named pTriplEx2-mtClytin.
- the vector pTriplEx2-mtClytin was used for the expression of mtClytin in bacterial systems.
- FIG. 1 shows the plasmid map of the vector pTriplEX2-mtClytin.
- FIG. 2 shows the plasmid map of the vector pcDNA3 -mtClytm.
- Bacterial expression was carried out in E. coli strain BL21 (DE3) by transforming the bacteria with the expression plasmids pTriplEX2-mtClytin and pTriplEX2.
- the transformed bacteria were incubated in LB medium at 37 ° C. for 3 hours and expression was induced for 4 hours by adding IPTG to a final concentration of 1 mM.
- the induced bacteria were harvested by centrifugation, resuspended in 50 mM Tris / HCl (pH 9.0) + 5 mM EDTA and disrupted by ultrasound. The lysate was then centrifuged for 15 minutes at 13000 revolutions per minute (16000 rcf) and the supernatant was removed.
- the supernatant (dilutions 1: 5; 1:10; 1:20 and 1:50 with Tris / HCl pH 9.0)) was kept in the dark for 3 hours with coelenterazine (10E-07 M Coelenterazine in Tris / HCl pH 9 0) incubated. Immediately after the addition of 5 mM calcium chloride, the bioluminescence was measured in the luminometer. The integration time of the measurement was 40 seconds.
- FIG. 3 shows the results of the bioluminescence measurement of mtClytin in bacteria.
- the constitutive eukaryotic expression was carried out in CHO cells by transfection of the cells with the expression plasmids pcDNA3 -mtClytin and pcDNA3.1 (+) in transient experiments.
- 10,000 cells per hole were plated in DMEM-F12 medium on 96-well microtiter plates and incubated at 37 ° C. overnight.
- the transfection was carried out using the Fugene 6 kit (Röche) according to the manufacturer's instructions.
- the transfected cells were incubated overnight at 37 ° C in DMEM-F12 medium.
- the medium was then removed and replaced by 50 ⁇ l of coelenterazine (10E-07 M coelenterazine in PBS).
- the cells were incubated for 3 hours at 37 ° C. and then ATP (adenosine triphosphate) was added to a final concentration of 1 ⁇ M.
- ATP adenosine triphosphate
- the measurement was started immediately after the addition in the luminometer.
- the integration time was 1 second with a total measurement time of 60 seconds.
- FIG. 4 shows the results of the bioliiminescence measurement of mtClytm in CHO cells.
- FIG. 7 shows the alignment of mtClytin with clytin (Clytia gregaria) at the nucleic acid level.
- FIG. 8 shows the alignment of mtClytin with clytin (Clytia gregaria) at the amino acid level.
- CHO cells were transiently transfected with pcDNA3-mtClytin or pcDNA-Obelin or pcDNA3 (without integrated cDNA). The transfection and measurement was carried out as described in Example 4. The measurement data were collected for a period of 60 seconds with an integration time of 1 second.
- Figures 5 and 6 show the results of the kinetic analysis of mtClytin and Obelin.
- the computer program MITOPROT was used to analyze the signal peptide of mtClytin (Claros et al., 1996). The following photoproteins were analyzed: Obelin (Q27709), Aequorin (P07164), Clytin (Q08121) and mtClytin (SEQ ID NO. 2).
- Hmax_100 14,000 12,600 1,601 5,060
- FIG. 9 shows the alignment of mtClytin, Clytin (Clytia gregaria) and Clytin-type2 at the amino acid level.
- Green Fluorescent Protein Properties, Applications, and Protocols (Chalfie, M. and Kain, S., eds) pp. 45-70. Wiley-Liss, Inc. Yang Te-Tuan, Yale Parisa, Kitts Paul A. Kain Seven R., Quantification of gene expresssion with a secreted alkaline phosphatase reporter System. Biotechniques. 1997 23 (6) 11 lOff
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2004800337823A CN1882608B (zh) | 2003-09-16 | 2004-09-03 | 分离的发光蛋白mtClytin及其用途 |
JP2006526546A JP4728240B2 (ja) | 2003-09-16 | 2004-09-03 | 単離発光タンパク質mtクリシンおよびその使用 |
CA002538903A CA2538903A1 (en) | 2003-09-16 | 2004-09-03 | Isolated photoprotein mtclytin, and use thereof |
US10/572,175 US7833749B2 (en) | 2003-09-16 | 2004-09-03 | Isolated photoprotein mtClytin, and use thereof |
ES04764797T ES2375610T3 (es) | 2003-09-16 | 2004-09-03 | Fotoproteina mtciclina aislada y su uso. |
EP04764797A EP1664102B1 (de) | 2003-09-16 | 2004-09-03 | Isoliertes photoprotein mtclytin, sowie dessen verwendung |
DK04764797.9T DK1664102T3 (da) | 2003-09-16 | 2004-09-03 | Isoleret photoprotein mtclytin, samt dets anvendelse |
AT04764797T ATE533779T1 (de) | 2003-09-16 | 2004-09-03 | Isoliertes photoprotein mtclytin, sowie dessen verwendung |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10342670.1 | 2003-09-16 | ||
DE10342670A DE10342670A1 (de) | 2003-09-16 | 2003-09-16 | Isoliertes Photoprotein mtClytin, sowie dessen Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005035559A1 true WO2005035559A1 (de) | 2005-04-21 |
Family
ID=34352845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/009843 WO2005035559A1 (de) | 2003-09-16 | 2004-09-03 | Isoliertes photoprotein mtclytin, sowie dessen verwendung |
Country Status (12)
Country | Link |
---|---|
US (1) | US7833749B2 (de) |
EP (1) | EP1664102B1 (de) |
JP (1) | JP4728240B2 (de) |
KR (1) | KR20070029630A (de) |
CN (2) | CN101514341B (de) |
AT (1) | ATE533779T1 (de) |
CA (1) | CA2538903A1 (de) |
DE (1) | DE10342670A1 (de) |
DK (1) | DK1664102T3 (de) |
ES (1) | ES2375610T3 (de) |
SG (1) | SG146640A1 (de) |
WO (1) | WO2005035559A1 (de) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2440273A (en) * | 2006-07-20 | 2008-01-23 | Chisso Corp | Calcium-binding phosphoproteins |
DE102007011241A1 (de) | 2007-03-08 | 2008-09-11 | Bayer Healthcare Ag | Isoliertes Photoprotein mtClytinDecay, sowie dessen Verwendung |
JP2013063093A (ja) * | 2006-06-02 | 2013-04-11 | President & Fellows Of Harvard College | タンパク質表面のリモデリング |
US9150626B2 (en) | 2006-06-02 | 2015-10-06 | President And Fellows Of Harvard College | Protein surface remodeling |
US9221886B2 (en) | 2009-04-28 | 2015-12-29 | President And Fellows Of Harvard College | Supercharged proteins for cell penetration |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5304275B2 (ja) * | 2009-01-29 | 2013-10-02 | Jnc株式会社 | アポクライティン−iiをコードするコドン最適化核酸およびその使用方法 |
JP5549113B2 (ja) | 2009-05-14 | 2014-07-16 | Jnc株式会社 | カルシウム結合発光蛋白質、それをコードする遺伝子およびその用途 |
US20110081661A1 (en) * | 2009-07-14 | 2011-04-07 | Millipore Corporation | Modified photoproteins with increased affinity for calcium and enhanced bioluminescence and uses thereof |
GB201501603D0 (en) * | 2015-01-30 | 2015-03-18 | Norwegian University Of Life Sciences And Hedmark University College | Method and product |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991001305A1 (en) * | 1989-07-22 | 1991-02-07 | University Of Wales College Of Medicine | Modified bioluminescent proteins and their use |
WO2003006497A2 (fr) * | 2001-07-12 | 2003-01-23 | Centre National De La Recherche Scientifique | Photoprotéines mutees et leurs applications |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648218A (en) * | 1993-02-12 | 1997-07-15 | Sealite Sciences, Inc. | Preparation of photoprotein conjugates and methods of use thereof |
ES2237643T3 (es) * | 2002-10-21 | 2005-08-01 | Axxam S.R.L. | Fotoproteina con bioluminiscencia mejorada. |
DE10257354A1 (de) * | 2002-12-09 | 2004-07-08 | Bayer Healthcare Ag | Isoliertes fluoreszierendes Protein CGFP, sowie dessen Verwendung |
-
2003
- 2003-09-16 DE DE10342670A patent/DE10342670A1/de not_active Withdrawn
-
2004
- 2004-09-03 KR KR1020067007173A patent/KR20070029630A/ko active IP Right Grant
- 2004-09-03 EP EP04764797A patent/EP1664102B1/de active Active
- 2004-09-03 WO PCT/EP2004/009843 patent/WO2005035559A1/de active Application Filing
- 2004-09-03 AT AT04764797T patent/ATE533779T1/de active
- 2004-09-03 SG SG200806861-1A patent/SG146640A1/en unknown
- 2004-09-03 DK DK04764797.9T patent/DK1664102T3/da active
- 2004-09-03 JP JP2006526546A patent/JP4728240B2/ja not_active Expired - Fee Related
- 2004-09-03 CA CA002538903A patent/CA2538903A1/en not_active Abandoned
- 2004-09-03 US US10/572,175 patent/US7833749B2/en active Active
- 2004-09-03 CN CN2009100023089A patent/CN101514341B/zh not_active Expired - Fee Related
- 2004-09-03 CN CN2004800337823A patent/CN1882608B/zh not_active Expired - Fee Related
- 2004-09-03 ES ES04764797T patent/ES2375610T3/es active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991001305A1 (en) * | 1989-07-22 | 1991-02-07 | University Of Wales College Of Medicine | Modified bioluminescent proteins and their use |
WO2003006497A2 (fr) * | 2001-07-12 | 2003-01-23 | Centre National De La Recherche Scientifique | Photoprotéines mutees et leurs applications |
Non-Patent Citations (5)
Title |
---|
DATABASE EMBL 10 March 2002 (2002-03-10), MARKOVA S. V. ET AL.: "Obelia geniculata apoobelin mRNA, complete cds", XP002305433, Database accession no. AF394688 * |
DATABASE UniProt 1 October 1994 (1994-10-01), INOUYE S. ET AL.: "Clytin precursor (Phialidin)", XP002300448, Database accession no. Q08121 * |
DUNSTAN S L ET AL: "Cloning and expression of the bioluminescent photoprotein pholasin from the bivalve mollusc Pholas dactylus.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. 31 MAR 2000, vol. 275, no. 13, 31 March 2000 (2000-03-31), pages 9403 - 9409, XP002305955, ISSN: 0021-9258 * |
INOUYE S ET AL: "CLONING AND SEQUENCE ANALYSIS OF CDNA FOR THE CA2+-ACTIVATED PHOTOPROTEIN, CLYTIN", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 315, no. 3, January 1993 (1993-01-01), pages 343 - 346, XP001180448, ISSN: 0014-5793 * |
MARKOVA SVETLANA V ET AL: "Obelin from the bioluminescent marine hydroid Obelia geniculata: Cloning, expression, and comparison of some properties with those of other Ca2+-regulated photoproteins", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 41, no. 7, 19 February 2002 (2002-02-19), pages 2227 - 2236, XP002232863, ISSN: 0006-2960 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013063093A (ja) * | 2006-06-02 | 2013-04-11 | President & Fellows Of Harvard College | タンパク質表面のリモデリング |
US10407474B2 (en) | 2006-06-02 | 2019-09-10 | President And Fellows Of Harvard College | Protein surface remodeling |
US9434774B2 (en) | 2006-06-02 | 2016-09-06 | President And Fellows Of Harvard College | Protein surface remodeling |
US9150626B2 (en) | 2006-06-02 | 2015-10-06 | President And Fellows Of Harvard College | Protein surface remodeling |
JP2013231037A (ja) * | 2006-07-20 | 2013-11-14 | Jnc Corp | カルシウム結合発光蛋白質、それをコードする遺伝子およびその用途 |
GB2440273B (en) * | 2006-07-20 | 2011-03-16 | Chisso Corp | Calcium-binding photoprotein, gene encoding the same and use thereof |
US8236526B2 (en) | 2006-07-20 | 2012-08-07 | Jnc Corporation | Calcium-binding photoprotein, gene encoding the same, and use thereof |
US7666980B2 (en) | 2006-07-20 | 2010-02-23 | Chisso Corporation | Calcium-binding photoprotein, gene encoding the same, and use thereof |
US8563270B2 (en) | 2006-07-20 | 2013-10-22 | Jnc Corporation | Calcium-binding photoprotein, gene encoding the same, and use thereof |
GB2440273A (en) * | 2006-07-20 | 2008-01-23 | Chisso Corp | Calcium-binding phosphoproteins |
JP2008022848A (ja) * | 2006-07-20 | 2008-02-07 | Chisso Corp | カルシウム結合発光蛋白質、それをコードする遺伝子およびその用途 |
WO2008107104A1 (de) * | 2007-03-08 | 2008-09-12 | Bayer Schering Pharma Aktiengesellschaft | Isoliertes photoprotein mtclytindecay, sowie dessen verwendung |
DE102007011241A1 (de) | 2007-03-08 | 2008-09-11 | Bayer Healthcare Ag | Isoliertes Photoprotein mtClytinDecay, sowie dessen Verwendung |
US9221886B2 (en) | 2009-04-28 | 2015-12-29 | President And Fellows Of Harvard College | Supercharged proteins for cell penetration |
Also Published As
Publication number | Publication date |
---|---|
CA2538903A1 (en) | 2005-04-21 |
CN1882608B (zh) | 2011-09-14 |
DK1664102T3 (da) | 2012-02-27 |
CN1882608A (zh) | 2006-12-20 |
KR20070029630A (ko) | 2007-03-14 |
CN101514341A (zh) | 2009-08-26 |
CN101514341B (zh) | 2011-12-14 |
EP1664102B1 (de) | 2011-11-16 |
SG146640A1 (en) | 2008-10-30 |
ATE533779T1 (de) | 2011-12-15 |
DE10342670A1 (de) | 2005-04-21 |
JP4728240B2 (ja) | 2011-07-20 |
US7833749B2 (en) | 2010-11-16 |
US20070275377A1 (en) | 2007-11-29 |
EP1664102A1 (de) | 2006-06-07 |
ES2375610T3 (es) | 2012-03-02 |
JP2007527708A (ja) | 2007-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008095622A2 (de) | Sekretierte luziferase mluc7 und deren verwendung | |
EP1664102B1 (de) | Isoliertes photoprotein mtclytin, sowie dessen verwendung | |
EP1572732B1 (de) | Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung | |
WO2005021591A1 (de) | Isoliertes photoprotein berovin, sowie dessen verwendung | |
DE102007011241A1 (de) | Isoliertes Photoprotein mtClytinDecay, sowie dessen Verwendung | |
WO2005000885A1 (de) | Isoliertes photoprotein bolinopsin, sowie dessen verwendung | |
EP1881992A2 (de) | Isoliertes photoprotein aqdecay sowie dessen verwendung | |
WO2006010454A1 (de) | Isoliertes photoprotein aequorin y89f, sowie dessen verwendung | |
WO2006108518A1 (de) | Isoliertes photoprotein gr-bolinopsin, sowie dessen verwendung | |
WO2006081976A1 (de) | MUTANTEN DES FLUORESZIERENDEN PROTEINS CGFPs, SOWIE DEREN VERWENDUNG | |
WO2007140983A1 (de) | FLUORESZIERENDE PROTEINE wfCGFP, SOWIE DEREN VERWENDUNG |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480033782.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2538903 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004764797 Country of ref document: EP Ref document number: 2006526546 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1431/DELNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067007173 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2004764797 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067007173 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10572175 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10572175 Country of ref document: US |